FindTrial
Sign In

The efficacy and outcome of sirolimus in different genotypes of low-flow vascular malformations

The efficacy and outcome of sirolimus in different genotypes of low-flow vascular malformations

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000036637
Enrollment
Unknown
Registered
2020-08-24
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low-flow Vascular Malformation

Interventions

grouped according to the type of gene mutation:Nil

Sponsors

Ninth People's Hospital, Shanghai JiaoTong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 60 Years

Inclusion criteria

Inclusion criteria: Low-flow vascular malformation patients.

Exclusion criteria

Exclusion criteria: Patients with sever or uncontrolled diseases which are not elegible to the clinical trail.

Design outcomes

Primary

MeasureTime frame
rate of lesion volume drease;—

Countries

China

Contacts

Public ContactLin Xiaoxi

The Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine

linxiaoxi@126.com+86 13701997136

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026